Related Experiment Video
Updated: Aug 15, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Understanding Health Disparities in Preeclampsia: A Literature Review
Mary B Conklin1,2, Brittney M Wells1, Emily M Doe1
1School of Medicine, Creighton University, Omaha, Nebraska.
Insights
Black patients experience higher rates of preeclampsia, a serious pregnancy condition, due to a complex mix of social factors and genetics. Further research is needed to understand and address these disparities in preeclampsia outcomes.
Area of Science:
- Obstetrics and Gynecology
- Genetics
- Public Health
Background:
- Preeclampsia is a significant cause of maternal and fetal morbidity and mortality.
- Black patients in the U.S. exhibit higher prevalence and adverse outcomes from preeclampsia compared to White and Hispanic populations.
- Existing disparities are linked to a combination of biological, social, and environmental factors.
Purpose of the Study:
- To review current literature on the influence of race, social determinants of health, and genetic profiles on preeclampsia prevalence and outcomes.
- To explore biosocial factors, genetic predispositions, and biomarkers contributing to racial disparities in preeclampsia.
- To identify areas for future research to mitigate negative outcomes in high-risk populations.
Main Methods:
- Systematic literature review of published studies.
- Searches conducted in PubMed using Medline search strategies and authors' expertise.
- Analysis of contributing biosocial factors, gene polymorphisms, and biomarkers related to preeclampsia disparities.
Main Results:
- Increased rates of comorbidities like hypertension and obesity in Black patients, linked to reduced healthcare access, contribute to higher preeclampsia prevalence.
- Limited research indicates potential associations between preeclampsia in Black patients and specific gene polymorphisms (e.g., APOL1, HLA-G, PP13) and Factor V Leiden mutation.
- The disparity in preeclampsia is multifactorial, requiring further investigation into genetic and biomarker roles.
Conclusions:
- Addressing the multifactorial nature of preeclampsia disparities requires understanding both biosocial determinants and genetic predispositions.
- Further research is essential to validate the role of specific biomarkers (serum, placental, urine) in predicting preeclampsia risk across different racial groups.
- Targeted research and interventions are necessary to reduce the disproportionately high rates and negative outcomes of preeclampsia among Black patients.
Abstract:
Preeclampsia is a multifactorial pathology with negative outcomes in affected patients in both the peripartum and postpartum period. Black patients in the United States, when compared to their White and Hispanic counterparts, have higher rates of preeclampsia. This article aims to review the current literature to investigate how race, social determinants of health, and genetic profiles influence the prevalence and outcomes of patients with preeclampsia. Published studies utilized in this review were identified through PubMed using authors' topic knowledge and a focused search through a Medline search strategy. These articles were thoroughly reviewed to explore the contributing biosocial factors, genes/biomarkers, as well as negative outcomes associated with disparate rates of preeclampsia. Increased rates of contributing comorbidities, including hypertension and obesity, which are largely associated with low access to care in Black patient populations lead to disparate rates of preeclampsia in this population. Limited research shows an association between increased rate of preeclampsia in Black patients and specific APOL1, HLA-G, and PP13 gene polymorphisms as well as factor V Leiden mutations. Further research is required to understand the use of certain biomarkers in predicting preeclampsia within racial populations. Understanding contributing biosocial factors and identifying genes that may predispose high-risk populations may help to address the disparate rates of preeclampsia in Black patients as described in this review. Further research is required to understand if serum, placental, or urine biomarkers may be used to predict individuals at risk of developing preeclampsia in pregnancy. KEY POINTS: · Prevalence of preeclampsia in the U.S. is higher in Black patients compared to other racial groups.. · Patients with preeclampsia are at risk for poorer health outcomes both during and after delivery.. · Limited research suggests specific biomarkers or gene polymorphisms contribute to this difference; however, explanations for this disparity are multifactorial and further investigation is necessary..
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pre-Procedural Guidelines for Assessing Blood Pressure
Hormonal Regulation
Factors affecting Blood pressure
Physiological Factors:
Diabetes Mellitus: Type 2 and Gestational

